FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

K Bolsen

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Disorders

Procedures

Photochemotherapy

Physiology

Enzyme Induction

Co-author Network

Publications

TOP 3
Sandra Hanneken; Marko Siegesmund; K Bolsen; Kerstin Gardlo; Norbert J Neumann
The prognostic value of cord blood analysis in erythropoietic protoporphyria: the 'Duesseldorf Cord Blood Study'.
F Wimmershoff; Kerstin Gardlo; K Bolsen; Thomas Ruzicka; Clemens Fritsch
[High-dose vitamin therapy as prophylaxis against porphyria cutanea uremica].
Tonio Wiederholt; Pamela Poblete Gutiérrez; Kerstin Gardlo; G Goerz; K Bolsen; Hans F Merk; Jorge Frank
Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of K Bolsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Sandra Hanneken; Marko Siegesmund; K Bolsen; Kerstin Gardlo; Norbert J Neumann
The prognostic value of cord blood analysis in erythropoietic protoporphyria: the 'Duesseldorf Cord Blood Study'.
Photodermatology, photoimmunology & photomedicine 2010;26(1):7-9.
2006: F Wimmershoff; Kerstin Gardlo; K Bolsen; Thomas Ruzicka; Clemens Fritsch
[High-dose vitamin therapy as prophylaxis against porphyria cutanea uremica].
Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete 2006;57(3):228, 230-2, 234-6.
2006: Tonio Wiederholt; Pamela Poblete Gutiérrez; Kerstin Gardlo; G Goerz; K Bolsen; Hans F Merk; Jorge Frank
Identification of mutations in the uroporphyrinogen III cosynthase gene in German patients with congenital erythropoietic porphyria.
Physiological research / Academia Scientiarum Bohemoslovaca 2006;55 Suppl 2():S85-92.
2004: Pamela Poblete Gutiérrez; Tonio Wiederholt; Kerstin Gardlo; K Bolsen; C Schnabel; Oliver Kunitz; Jorge Frank
[Porphyria: from clinics to molecular genetics].
Annales de dermatologie et de vénéréologie 2004;131(8-9):825-8.
2003: Kerstin Gardlo; Dennis Selimovic; K Bolsen; Thomas Ruzicka; Josef Abel; Clemens Fritsch
Cytochrome p450A1 polymorphisms in a Caucasian population with porphyria cutanea tarda.
Experimental dermatology 2003;12(6):843-8.
2001: K Lang; K Bolsen; Wilhelm Stahl; Thomas Ruzicka; Helmut Sies; Percy Lehmann; Clemens Fritsch
The 5-aminolevulinic acid-induced porphyrin biosynthesis in benign and malignant cells of the skin.
Journal of photochemistry and photobiology. B, Biology 2001;65(1):29-34.
2001: K Lang; Percy Lehmann; K Bolsen; Thomas Ruzicka; Clemens Fritsch
Aminolevulinic acid: pharmacological profile and clinical indication.
Expert opinion on investigational drugs 2001;10(6):1139-56.
1999: Anastasios Kalofoutis; Alexandra Monastirli; Aggeliki Papapanagiotou; Sophia Georgiou; Efi Pasmatzi; Th Sakkis; K Bolsen; G Goerz; Hans F Merk; Dionysios Tsambaos
Alterations of rat liver phospholipid composition induced by oral thalidomide.
Skin pharmacology and applied skin physiology 1999;12(6):312-6.
1999: Alexandra Monastirli; Sophia Georgiou; K Bolsen; Efi Pasmatzi; Aggeliki Papapanagiotou; G Goerz; Anastasios Kalofoutis; Hans F Merk; Dionysios Tsambaos
Treatment of porphyria cutanea tarda with oral thalidomide.
Skin pharmacology and applied skin physiology 1999;12(6):305-11.
1998: Clemens Fritsch; K Lang; K Bolsen; Percy Lehmann; Thomas Ruzicka
Congenital erythropoietic porphyria.
Skin pharmacology and applied skin physiology 1998;11(6):347-57.
1998: Clemens Fritsch; K Lang; S von Schmiedeberg; K Bolsen; H Merk; Percy Lehmann; Thomas Ruzicka
Porphyria cutanea tarda.
Skin pharmacology and applied skin physiology 1998;11(6):321-35.
1997: Christoph Abels; Clemens Fritsch; K Bolsen; Rolf-Markus Szeimies; Thomas Ruzicka; G Goerz; Alwin E Goetz
Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo.
Journal of photochemistry and photobiology. B, Biology 1997;40(1):76-83.
1997: Clemens Fritsch; J Batz; K Bolsen; Klaus W Schulte; M Zumdick; Thomas Ruzicka; G Goerz
Ex vivo application of delta-aminolevulinic acid induces high and specific porphyrin levels in human skin tumors: possible basis for selective photodynamic therapy.
Photochemistry and photobiology 1997;66(1):114-8.
1997: G Goerz; K Bolsen; H Böhrer; Clemens Fritsch; K Kalka; K L Rominger
Effects of clonidine in a primed rat model of acute hepatic porphyria.
Arzneimittel-Forschung 1997;47(6):731-3.
1997: Clemens Fritsch; K Bolsen; Thomas Ruzicka; G Goerz
Congenital erythropoietic porphyria.
Journal of the American Academy of Dermatology 1997;36(4):594-610.
1997: K Kalka; Clemens Fritsch; K Bolsen; B Verwohlt; G Goerz
Influence of indoles (melatonin, serotonin and tryptophan) on the porphyrin metabolism in vitro.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1997;10(4):221-4.
1997: Clemens Fritsch; Christoph Abels; Alwin E Goetz; Wilhelm Stahl; K Bolsen; Thomas Ruzicka; G Goerz; Helmut Sies
Porphyrins preferentially accumulate in a melanoma following intravenous injection of 5-aminolevulinic acid.
Biological chemistry 1997;378(1):51-7.
1996: G Goerz; W Barnstorf; G Winnekendonk; K Bolsen; Clemens Fritsch; K Kalka; Dionysios Tsambaos
Influence of UVA and UVB irradiation on hepatic and cutaneous P450 isoenzymes.
Archives of dermatological research 1996;289(1):46-51.
1996: Daniela Bruch-Gerharz; K Bolsen; C D Gerharz; G Goerz
Erythropoietic protoporphyria and terminal hepatic failure.
Acta dermato-venereologica 1996;76(6):453-6.
1996: G Herrmann; Meinhard Wlaschek; K Bolsen; K Prenzel; G Goerz; Karin Scharffetter-Kochanek
Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts.
The Journal of investigative dermatology 1996;107(3):398-403.
1996: Clemens Fritsch; B Verwohlt; K Bolsen; T Ruzicka; G Goerz
Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism.
Archives of dermatological research 1996;288(9):517-21.
1996: G Goerz; S Bunselmeyer; K Bolsen; N Y Schürer
Ferrochelatase activities in patients with erythropoietic protoporphyria and their families.
The British journal of dermatology 1996;134(5):880-5.
1996: W Dietel; K Bolsen; E Dickson; Clemens Fritsch; R Pottier; R Wendenburg
Formation of water-soluble porphyrins and protoporphyrin IX in 5-aminolevulinic-acid-incubated carcinoma cells.
Journal of photochemistry and photobiology. B, Biology 1996;33(3):225-31.
1996: J von Laar; Wilhelm Stahl; K Bolsen; G Goerz; Helmut Sies
Beta-carotene serum levels in patients with erythropoietic protoporphyria on treatment with the synthetic all-trans isomer or a natural isomeric mixture of beta-carotene.
Journal of photochemistry and photobiology. B, Biology 1996;33(2):157-62.
1995: G Goerz; A Link-Mannhardt; K Bolsen; M Zumdick; Clemens Fritsch; N Y Schürer
Porphyrin concentrations in various human tissues.
Experimental dermatology 1995;4(4 Pt 1):218-20.
1995: G Goerz; Dionysios Tsambaos; Hans-Christian Schuppe; K Bolsen; Sophia Georgiou; S Reinauer; C Zografakis
Effects of human recombinant interferon-alpha 2b on P450-dependent isozymes in rat liver and skin.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1995;8(3):162-6.
1994: G Goerz; K Bolsen; S Bunselmeyer; N Y Schürer
Recessive inheritance of erythropoietic protoporphyria with liver failure.
Lancet 1994;344(8918):337.
1994: G Goerz; K Bolsen; Anastasios Kalofoutis; Dionysios Tsambaos
Influence of oral isotretinoin on hepatic and cutaneous P-450-dependent isozyme activities.
Archives of dermatological research 1994;286(2):104-6.
1994: Dionysios Tsambaos; K Bolsen; Sophia Georgiou; Alexandra Monastirli; G Goerz
Effects of oral thalidomide on rat liver and skin microsomal P450 isozyme activities and on urinary porphyrin excretion: interaction with oral hexachlorobenzene.
Archives of dermatological research 1994;286(6):347-9.
1994: Dionysios Tsambaos; K Bolsen; Sophia Georgiou; Anastasios Kalofoutis; G Goerz
Effects of oral administration of acitretin on rat liver microsomal phospholipids, P-450 content and monooxygenase activities.
Skin pharmacology : the official journal of the Skin Pharmacology Society 1994;7(6):320-3.
1993: G Goerz; K Bolsen; E Vardarman; K L Rominger
Influence of clonidine on the porphyrin metabolism in female rats.
Arzneimittel-Forschung 1993;43(12):1309-12.
1993: Meinhard Wlaschek; K Bolsen; G Herrmann; A Schwarz; F Wilmroth; P C Heinrich; G Goerz; Karin Scharffetter-Kochanek
UVA-induced autocrine stimulation of fibroblast-derived-collagenase by IL-6: a possible mechanism in dermal photodamage?
The Journal of investigative dermatology 1993;101(2):164-8.
1991: T Schaefer; K Scharffetter; K Bolsen; Frank K Jugert; Percy Lehmann; Hans F Merk; G Goerz
Effect of UVASUN on porphyrin metabolism and P-450 isoenzymes in hexachlorobenzene-induced porphyric rats.
Current problems in dermatology 1991;20():106-15.
1991: K Scharffetter; Meinhard Wlaschek; A Hogg; K Bolsen; A Schothorst; G Goerz; Thomas Krieg; Gerd Plewig
UVA irradiation induces collagenase in human dermal fibroblasts in vitro and in vivo.
Archives of dermatological research 1991;283(8):506-11.
1990: Percy Lehmann; T Schäfer; K Bolsen; G Goerz
[Animal experiment model of the effect of ultraviolet irradiation on hexachlorobenzene-induced porphyria].
Dermatosen in Beruf und Umwelt. Occupation and environment 1990;38(5):148-9, 151-4.